Clinical Trials Directory

Trials / Completed

CompletedNCT00965627

Biology of Thymic Tumors

Biological Analysis of a Series of Thymoma and Thymic Carcinoma: Genetic Aberrations and Potential Therapy Targets.

Status
Completed
Phase
Study type
Observational
Enrollment
134 (actual)
Sponsor
Istituto Clinico Humanitas · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a retrospective analysis of biological characteristics of thymoma and thymic carcinoma patients.

Detailed description

The aim of the present study is to investigated the genetic alterations in tumor samples of a series of all WHO-defined subtypes of thymoma patients using high resolution microarray- comparative genomic hybridization (CGH) followed by hierarchical cluster analyses of the data to identify specific patterns of genetic aberrations and genes associated with each subtype. Moreover, tumor samples will be also investigated for some specific potential therapy targets by immunoistichemistry, mutation analysis, and fluorescence in situ hybridization (FISH) analysis. All these biological data will be correlated with clinical patients characteristics and survival data.

Conditions

Timeline

Start date
2008-06-01
Primary completion
2008-08-01
Completion
2009-08-01
First posted
2009-08-25
Last updated
2009-08-28

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT00965627. Inclusion in this directory is not an endorsement.

Biology of Thymic Tumors (NCT00965627) · Clinical Trials Directory